## Core Concept
Juxtafoveal retinal telangiectasias (JRT) refer to a group of retinal disorders characterized by abnormal dilation of retinal vessels near the fovea. These conditions can lead to visual impairment due to retinal edema, hard exudates, and potential damage to the foveal photoreceptors. The classification and management of JRT are critical in ophthalmology.

## Why the Correct Answer is Right
The correct answer, although not directly provided, would relate to a statement that does not align with known characteristics or clinical features of juxtafoveal retinal telangiectasias. Typically, JRT presents with specific clinical and diagnostic features, including leakage of fluorescein dye on angiography, presence of hard exudates, and sometimes, cystoid macular edema. A statement contradicting these established facts or suggesting an incorrect treatment approach would be the one that stands out as not belonging.

## Why Each Wrong Option is Incorrect
Without specific details on options A, B, C, and D, a general approach to evaluating incorrect statements about JRT includes:
- **Option A:** If a statement accurately describes a common cause, symptom, or diagnostic criterion for JRT, it would not be the correct answer to the "EXCEPT" question.
- **Option B:** Similarly, if another option aligns with current understanding and clinical practice regarding JRT, it would be incorrect to label it as the exception.
- **Option C:** This option would also be incorrect if it reflects a true aspect of JRT, such as its classification, typical patient demographics, or treatment goals.
- **Option D:** The statement in this option, if true, would not be the exception.

## Clinical Pearl / High-Yield Fact
A key point to remember is that juxtafoveal retinal telangiectasias can be idiopathic or secondary to other conditions. The idiopathic form, also known as idiopathic juxtafoveal retinal telangiectasis, primarily affects middle-aged adults and can lead to progressive visual loss. Early recognition and, in some cases, treatment with intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections or laser photocoagulation can help manage the condition and potentially stabilize or improve vision.

## Correct Answer Line
**Correct Answer: D.**